EI- Nile for Pharmaceuticals and Chemical Industries Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 501,165 | 4.95% |
| Employee Share Scheme | 506,250 | 5% |
| General Public | 2,150,891 | 21.2% |
| Private Companies | 6,966,694 | 68.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 6,750,000 | ج.م372.7m | 0% | no data | |||
| 506,250 | ج.م28.0m | 0% | no data | |||
| 298,640 | ج.م16.5m | 0.65% | no data | |||
| 216,694 | ج.م12.0m | 2.44% | no data | |||
| 104,077 | ج.م5.7m | 0% | no data | |||
| 79,100 | ج.م4.4m | 0% | no data | |||
| 19,348 | ج.م1.1m | 0% | no data |